The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Merck
Stock and Other Ownership Interests - Merck
Pembrolizumab plus chemoradiation vs chemoradiation alone for locally advanced head and neck squamous cell carcinoma: The phase 3 KEYNOTE-412 study.
 
Jean-Pascal H. Machiels
Consulting or Advisory Role - Boehringer Ingelheim; Debiopharm Group; Innate Pharma; Merck Sharp & Dohme; Nanobiotix; Pfizer
Research Funding - Bayer; Janssen; Novartis; Sanofi
 
Lisa F. Licitra
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Debiopharm Group; Eisai; Merck Serono; MSD; Novartis; Roche; SOBI
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Debiopharm Group; Merck Serono; SOBI
 
Yungan Tao
No Relationships to Disclose
 
Chia-Jui Yen
No Relationships to Disclose
 
Danny Rischin
Research Funding - Amgen; Bristol-Myers Squibb; Genentech/Roche; Merck; Regeneron
 
John Waldron
No Relationships to Disclose
 
Barbara Burtness
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Debiopharm Group; MedImmune; Merck; VentiRx
Research Funding - Merck
 
Vincent Gregoire
No Relationships to Disclose
 
Sanjiv S. Agarwala
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Jeffrey Yorio
No Relationships to Disclose
 
Jean-Pierre Delord
No Relationships to Disclose
 
Sercan Aksoy
Honoraria - Abdi Ibrahim; Astellas Oncology; Merck; Novartis; Roche
Consulting or Advisory Role - Abdi Ibrahim; Merck; Pfizer
 
Sadakatsu Ikeda
No Relationships to Disclose
 
Ruey-Long Hong
No Relationships to Disclose
 
Joy Yang Ge
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Holly M. Brown
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Behzad Bidadi
No Relationships to Disclose
 
Lillian L. Siu
Leadership - Agios (I)
Consulting or Advisory Role - AstraZeneca/MedImmune; Merck; MorphoSys; Symphony Evolution
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Symphony Evolution (Inst)